While men are currently more likely to smoke than women, this sex/gender gap is narrowing globally. This is especially concerning given that compared to men, women are at higher risk for smoking-related adverse health effects and also have a more difficult time quitting smoking. This seminar provides an overview of the trends of use and cessation outcomes by sex/gender, as well as factors contributing to these sex/gender differences.
This one-hour seminar was developed for nicotine and tobacco researchers interested in sex/gender differences in combustible tobacco use. It may also provide useful background information for clinicians who work with women who smoke.
The seminar includes a presentation by Dr. Sherry McKee of Yale University, covering the following topics:
This one-hour seminar was developed for nicotine and tobacco researchers interested in sex/gender differences in combustible tobacco use. It may also provide useful background information for clinicians who work with women who smoke.
The seminar includes a presentation by Dr. Sherry McKee of Yale University, covering the following topics:
- Prevalence and trends over time
- Health effects in women and babies
- Differences in quit outcomes in women versus men (with and without medications)
- Factors contributing to difficulties with cessation
- Emerging research on novel approaches to improve cessation outcomes in women.
Learning objectives
By completing this course, learners will:
- Know the current prevalence and overall trends of combustible tobacco use in women compared to men
- Gain an understanding of the health effects of smoking in women
- Understand cessation outcomes in women versus men with various pharmacotherapies
- Be able to identify factors contributing to difficulties with cessation in women.
Questions or comments on this seminar? Email SRNT-U
SRNT University is grateful to Dr. Elise DeVito at Yale University School of Medicine for developing this seminar's quiz.